The weekly litigation news digest is live. Subscribe now

IP Verse

Cyclic Ntcp-Targeting Peptides And Their Uses As Entry Inhibitors

Patent No. EP3389691 (titled "Cyclic Ntcp-Targeting Peptides And Their Uses As Entry Inhibitors") was filed by Ruprecht Karls Universitt Heidelberg on Dec 15, 2016. The application was issued on May 6, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONFeb 5, 2021MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3389691

RUPRECHT KARLS UNIVERSITT HEIDELBERG
Application Number
EP16822406A
Filing Date
Dec 15, 2016
Status
Revoked
Jul 18, 2025
Publication Date
May 6, 2020
External Links
Slate, Register, Google Patents